The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells.
Copertino DC Jr, Holmberg CS, Weiler J, Ward AR, Howard JN, Levinger C, Pang AP, Corley MJ, Dündar F, Zumbo P, Betel D, Gandhi RT, McMahon DK, Bosch RJ, Linden N, Macatangay BJ, Cyktor JC, Eron JJ, Mellors JW, Kovacs C, Benko E, Bosque A, Jones RB; AIDS Clinical Trials Group (ACTG) A5321 Team.
Copertino DC Jr, et al. Among authors: zumbo p.
JCI Insight. 2023 Sep 22;8(18):e169028. doi: 10.1172/jci.insight.169028.
JCI Insight. 2023.
PMID: 37581929
Free PMC article.